Aug
26
Birmingham, West Midlands — (TechSonian) — 08/26/2014 —GenthermInc(NASDAQ:THRM)designs, develops, and manufactures thermal management technologies and cable systems worldwide. It operates through three segments: Climate Controlled Seats (CCS), Advanced Technology, and W.E.T.
GenthermInc(NASDAQ:THRM)advanced3.32% and closed at $ 46.64 in the last trading session with the total traded volume of 542,308.00 shares. That’s more than the average volume of 614,982.00. It has outstanding shares of 35.47million with the total market cap of $ 1.60 billion and its year-to-date (YTD) performance remained in bullish zone as reported the gain of 84.13%.
For How Long THRM will fight for Profitability? Read This Trend Analysis report
GrupoFinanciero Galicia S.A. (ADR)(NASDAQ:GGAL)operates as a financial services holding company in Argentina. The company operates through Banking, Regional Credit Cards, CFA Personal Loans, and Insurance segments.
GrupoFinanciero Galicia S.A. (ADR)(NASDAQ:GGAL) close at $ 12.76 and its overall volume in the last trading session was 542,233.00 shares, beating the average volume of 980,317.00. The share price scored the day-high of $ 13.28 and day low of $ 12.65. The stock is trading with positive year-to-date (YTD) performance of + 22.22 %. The company has total market cap of $ 1.80 billion.
Can GGAL Show a Strong Recovery? Find out in This Research Report
EpizymeInc(NASDAQ:EPZM)recently declared second quarter 2014 operating and financial results and reiterated 2014 guidance.“Epizyme is well-positioned to continue creating innovative personalized therapeutics for patients in need and value for our shareholders,” said Jason Rhodes, President and Chief Financial Officer, Epizyme. “We began 2014 with $157.2 million in cash, cash equivalents and accounts receivable and ended the second quarter of 2014 with $232.1 million in cash, cash equivalents and accounts receivable.
EpizymeInc(NASDAQ:EPZM)went up6.97% and closed at $ 35.92 with the total traded volume of 539,956.00 shares. Its opening price was $ 33.71 and its shares traded within the range of $ 33.71-$ 36.79. The company now has market cap of about $ 1.13 billion.
Why Should Investors Buy EPZM After the Recent Fall? Just Go Here and Find Out
Dynavax Technologies Corporation(NASDAQ:DVAX)recently reported financial results for the second quarter ended June 30, 2014 and pharmacodynamic and safety results from clinical studies of its asthma drug candidate partnered with AstraZeneca and its systemic lupus erythematosus (SLE) drug candidate partnered with GlaxoSmithKline.
Dynavax Technologies Corporation(NASDAQ:DVAX)with the closing price of $ 1.43. The overall volume in the last trading session was 539,558.00 shares. Its fifty two week range was $ 1.43-$ 1.46. The total market capitalization remained $ 375.92 million. Its last 5 day performance was -2.05%. In its share capital, the company has 375.92 million outstanding shares.
Can DVAX Show a Strong Recovery? Find out in This Research Report
Open all references in tabs: [1 – 5]
Comments
Leave a Reply
You must be logged in to post a comment.